On April 12, 2022, Mylan Pharmaceuticals Inc. recalled one batch of insulin. Labels were missing on one batch of Insulin Glargine Injection. This package is an unbranded Insulin Glargine- yfgn vial and product information, batch number and expiry date information are present on the carton. Insulin Glargine was distributed in the United States between December…
Read more
SYMJEPI Defect Recall
Imagine having an allergic reaction and the medication to save your life cannot be dispensed. SYMJEPI is an emergency treatment for patients who have an allergic reaction to something or anaphylaxis to stinging insects, allergen immunotherapy, foods, drugs, diagnostic testing substances and more. This injection is an emergency Epinephrine medication that is injected into patient…
Read more
Overcoming the Challenges of Small Batch Production
Focusing on a targeted group of patients and trials has led to more small batch productions throughout the industry. These products are often expensive and very limited within the pharmaceutical industries. When having a limited amount of product for manufacturing, issues and rejects must be near zero. Although, product loss is unavoidable—most product loss is…
Read more
Recall of Sodium Acetate Injection Due to the Presence of Particulate Matter
Fresenius Kabi is a global health care company that produces and specializes in medication and infusion/transfusion technology. Fresenius Kabi USA voluntarily recalled seven lots of Sodium Acetate Injection on Monday, March 7th. Various amounts of iron, sodium, silicon, chromium, aluminum and cellulose found in these injections led to seven lots being recalled. The presence of…
Read more